Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Tesamorelin vs Whey Protein: Whey Protein has the stronger overall evidence (9 vs 5/10); the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Whey Protein wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Likely helps
11 of 12 studies with measurable effects showed benefit.
Top outcomes
Approved regimen (Egrifta, HIV-associated lipodystrophy only): 2 mg once daily by subcutaneous injection. This is a prescription drug — the dose, indication and monitoring are set by a prescriber. The cognition RCT used a lower 1 mg/day. There is NO validated dose for off-label 'anti-aging' or physique use, and any such use is outside the evidence base.
Any time of day
Egrifta / Egrifta SV (prescription, via a clinician)
20-40g per serving
Before or after training, Morning, Between meals
Whey Protein Isolate
and 1 more not shown
26-52 weeks
6-12 months
Within months of stopping
20-24 weeks
4-8 weeks
24-48 hours post-workout
Immediate
Within hours of consumption
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
J Clin Endocrinol Metab (2010) · Rct · n=806
Pooled analysis of two multicenter, double-blind, placebo-controlled phase-3 RCTs (n=806 ART-treated HIV patients with excess abdominal fat), randomized 2:1 to tesamorelin 2 mg or placebo subcutaneously daily
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.
J Acquir Immune Defic Syndr (2010) · Rct · n=404
12-month phase-3 RCT in 404 ART-treated HIV patients with excess abdominal fat; randomized 2:1 to tesamorelin 2 mg sc daily or placebo, then rerandomized at 6 months
Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.
AIDS (2008) · Rct · n=410
26-week safety-extension RCT (n=410) of the phase-3 program; tesamorelin 2 mg vs placebo subcutaneously daily, with rerandomization at week 26
Comparative Efficacy of Different Protein Supplements on Muscle Mass, Strength, and Physical Indices of Sarcopenia among Community-Dwelling, Hospitalized or Institutionalized Older Adults Undergoing Resistance Training: A Network Meta-Analysis of Randomized Controlled Trials
Nutrients (2024) · Meta analysis · n=5272
We finally included 78 RCTs (5272 participants) for analyses.
Effects of Whey Protein, Leucine, and Vitamin D Supplementation in Patients with Sarcopenia: A Systematic Review and Meta-Analysis
Nutrients (2023) · Meta analysis · n=637
Three RCTs, 637 patients with sarcopenia, of combined whey protein, leucine and vitamin D.
A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength
British Journal of Sports Medicine (2018) · Meta analysis · n=1863
49 RCTs, 1863 participants: protein supplementation increased 1RM strength (2.49 kg), fat-free mass (0.30 kg) and muscle fibre cross-sectional area during prolonged resistance training.
The points come from one dose-comparison RCT in 48 resistance-trained young men, who took 0, 10, 20 or 40 g of whey protein isolate straight after leg exercise, three hours after a high-protein breakfast (PMID 24257722). Over the next four hours myofibrillar muscle protein synthesis rose 49% above 0 g with 20 g and 56% with 40 g, and 10 g gave no added stimulation. The authors conclude 20 g is enough for the maximal response in about 80 kg men, and 40 g mainly raised amino acid oxidation and urea production. This is an acute measure of protein synthesis, not muscle growth over weeks of training, and the trial did not report tolerability, so no ceiling dose is set.
AI-estimated from published studies. Interpret as directional guidance.
Whey Protein has a higher evidence score (9/10 vs 5/10) and wins in 3 of 3 categories.
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
The transition years (40s): cycle changes, mood, sleep, brain fog — foundations, vitex, and starting muscle work early.
Start with 2–3 foundations, add one at a time, build by goal — without wasting money.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.